Ropes & Gray represented CAMP4 Therapeutics in the transaction, and Paul Hastings represented the underwriters. CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company, announced...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Sanofi on the transaction, and Goodwin Procter advised Vigil Neuroscience. Sanofi (Nasdaq: SNY) has made a $40 million strategic investment in Vigil...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton is advising Ambac Financial Group on the deal, and RPC along with Ropes & Gray are advising Beat Capital Partners Limited and Bain...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, announced the closing a transaction with Bayer for a...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, signed an agreement with Bayer to expand Ginkgo’s platform capabilities...
You must be a Standard 1 Year member to access this content.
Zhong Lun and Ropes & Gray advised LianBio on the deal. LianBio executed an initial public offering and listing of American depositary shares on the Nasdaq...
You must be a Standard 1 Year member to access this content.
